Sensex, Nifty hit record highs as Pfizer’s vaccine trial success

Sensex, Nifty hit record highs as Pfizer’s vaccine trial success

Indian benchmark indices touched record highs on Tuesday after US-based Pfizer and its German partner BioNTech announced that its experimental vaccine is more than 90 percent effective, based on initial trial results.

Both the S&P BSE Sensex and NSE Nifty 50 registered strong gains as shares of companies such as airlines and hotels surged in morning trade. Pfizer’s initial late-stage trial data has also boosted investor sentiment across the globe.

At around 11:30 am, Sensex was trading 428 points higher at over 43,000 points, while Nifty was trading almost 1 percent higher at 12,570. Banking and financial stocks were up after renewed vaccine hopes.